{"data":[{"accessionNo":"0001104659-26-097278","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":5475040,"percentOfClass":8.22,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001104659-26-097278","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":5475040,"percentOfClass":8.22,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001104659-26-097278","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":5475040,"percentOfClass":8.22,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000919574-26-005528","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Montanova Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3680921,"percentOfClass":5.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000919574-26-005528","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Aaron Cowen","reportingCik":null,"personType":"HC,IN","sharesOwned":3680921,"percentOfClass":5.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000919574-26-005528","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Averill Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2553201,"percentOfClass":3.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001231919-26-000923","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-352345","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-352345","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-352345","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001231919-26-000923","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001231919-26-000923","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001231919-26-000923","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000070858-26-000396","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":4468123,"percentOfClass":6.7,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0002012383-26-002576","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS INC","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4802880,"percentOfClass":7.2,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0002052113-26-000745","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS INC","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":4021379,"percentOfClass":6,"filedAt":"2026-07-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":6913329,"percentOfClass":10.4,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":6913329,"percentOfClass":10.4,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":2160423,"percentOfClass":3.2,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":1630127,"percentOfClass":2.5,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":1630142,"percentOfClass":2.5,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-008613","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-07-13","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":1492637,"percentOfClass":2.2,"filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000331","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":6000000,"percentOfClass":9,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000330","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":6000000,"percentOfClass":9,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000330","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":6000000,"percentOfClass":9,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000331","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":6000000,"percentOfClass":9,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000330","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5614199,"percentOfClass":8.4,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000935836-26-000331","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-06-17","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5614199,"percentOfClass":8.4,"filedAt":"2026-06-25","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":5451800,"percentOfClass":8.2,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":5451800,"percentOfClass":8.2,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":1703690,"percentOfClass":2.5,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":1249370,"percentOfClass":1.9,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":1249373,"percentOfClass":1.9,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001214659-26-007338","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-03","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":1249367,"percentOfClass":1.9,"filedAt":"2026-06-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-226891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":5250000,"percentOfClass":7.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-226891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5250000,"percentOfClass":7.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001193125-26-226891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":5250000,"percentOfClass":7.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001104659-26-062675","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":3050040,"percentOfClass":4.58,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001104659-26-062675","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":3050040,"percentOfClass":4.58,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001104659-26-062675","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":"359616109","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":3050040,"percentOfClass":4.58,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000102909-26-001344","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics Inc","ticker":"FULC","cusip":"359616109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-26-000043","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":6649973,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-26-000043","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":6649973,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-26-000043","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":6649973,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-26-000043","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6649973,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-25-000068","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":6053960,"percentOfClass":11.2,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-25-000068","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":6053960,"percentOfClass":11.2,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-25-000068","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":6053960,"percentOfClass":11.2,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0001346824-25-000068","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS, INC.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-08","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6053960,"percentOfClass":11.2,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000902664-25-004883","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2432000,"percentOfClass":4.5,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000902664-25-004883","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":2432000,"percentOfClass":4.5,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0000902664-25-004883","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001680581","issuerName":"Fulcrum Therapeutics, Inc.","ticker":"FULC","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":2432000,"percentOfClass":4.5,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"},{"accessionNo":"0002012383-25-002864","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001680581","issuerName":"FULCRUM THERAPEUTICS INC","ticker":"FULC","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3270322,"percentOfClass":6,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/fulc"}],"updatedAt":"2026-10-24T16:09:13.499Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/fulc","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}